Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa in Spinal Surgery
NCT00211146Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Apr 1998
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Johnson & Johnson. Started Apr 1998; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00211146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211146.